Загрузка...
CHD7 Expression Predicts Survival Outcomes in Patients with Resected Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with poor outcomes with current therapies. Gemcitabine is the primary adjuvant drug used clinically, but its effectiveness is limited. In this study, our objective was to utilize a rationale-driven approach to identify novel biomarkers...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4025946/ https://ncbi.nlm.nih.gov/pubmed/24626090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-1996 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|